Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in FXTAS
NCT02197104Phase 2Completed
- Sponsor
- Rush University Medical Center
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of citicoline in Fragile X-associated tremor/ataxia syndrome (FXTAS), sponsored by Rush University Medical Center. Started Jan 2015; status: completed.
02
Drugs
citicoline
03
Conditions
Fragile X-associated tremor/ataxia syndrome (FXTAS)
Beyond the preview
Go deeper on NCT02197104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197104.